VENMAX DRUGS AND PHARMACEUTICA Share Price

VENMAX DRUGS AND PHARMACEUTICA Share Price

BSE: 531015
|
Pharmaceuticals
₹ 16.35
-₹0.55 (-3.25%)
1D
Last updated 24 Jul, 2026, 15:29 IST

VENMAX DRUGS AND PHARMACEUTICA Share Price Today

As of 25 Jul 2026, VENMAX DRUGS AND PHARMACEUTICA share price is ₹16.35. The stock opened at ₹16.31, compared to its previous close of ₹16.90. During today's trading session, VENMAX DRUGS AND PHARMACEUTICA share price moved in the range of ₹15.57 to ₹17.00, with an average price of ₹16.29 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.56 and a high of ₹36.96.

₹15.57
3.25% down today
₹17.00
1D LOW
1D HIGH

VENMAX DRUGS AND PHARMACEUTICA Returns Calculator

Circuit
L
H
₹13.52
₹20.28
52-week
L
H
₹15.56
₹36.96
Mkt Cap Cr
19.58
P/E
80.48
P/B
1.39
ROE
1.76%
D/E
0.02
ROCE
1.92%
Div. Yield
0.00%
EPS(TTM)
0.21
Turnover
0.57
EV/EBITDA
78.61
Net Margin
0.00%
Op. Margin
0.00%
ROA
1.23%
Quick Ratio
0.00
Curr. Ratio
9.23
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Venmax Drugs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Venmax Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,68,842.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,607.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories97,364.9030.582.5611.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

VENMAX DRUGS AND PHARMACEUTICA Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.81₹0.00₹0.00₹0.00
Other Income₹1.05₹0.20₹0.42₹1.98
Total Revenue₹1.86₹0.20₹0.42₹1.98
Total Expenses₹1.87₹0.11₹0.19₹0.14
Profit Before Tax-₹0.01₹0.09₹0.23₹1.85
Tax₹0.00₹0.02₹0.00₹0.00
Profit After Tax-₹0.01₹0.06₹0.23₹1.85
EPS - Basic-₹0.02₹0.12₹0.43₹3.52
EPS - Diluted-₹0.02₹0.12₹0.43₹3.52

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.01₹0.09₹0.23₹1.85
Income before WC changes₹0.01₹0.09₹0.23₹1.86
Change in Assets-₹2.63₹0.13-₹0.09₹0.01
Change in Liabilities₹0.33-₹0.19-₹0.14₹0.04
Change in WC-₹2.30-₹0.07-₹0.24₹0.05
Cash flow from Operations-₹2.29₹0.00₹0.00₹1.91
Cash flow from Investing₹0.00₹0.00₹0.00₹0.00
Cash flow from Financing₹4.77₹0.00₹0.00-₹1.98
Total Cash Flow₹2.48₹0.00₹0.00-₹0.07
Cash (Start of the year)₹0.00₹0.00₹0.00₹0.08
Cash (End of the year)₹2.48₹0.00₹0.00₹0.00

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.04₹0.07₹0.07₹0.08
Current Assets₹5.13₹0.02₹0.14₹0.13
Total Assets₹5.17₹0.08₹0.21₹0.21
Current Liabilities₹0.76₹0.73₹0.92₹1.15
Net Current Asset₹4.37-₹0.71-₹0.78-₹1.02
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹4.41-₹0.65-₹0.71-₹0.94
Total Equity & Liabilities₹5.17₹0.08₹0.21₹0.21
* All values are in INR Crore
Qty
Bid
200
15.94
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 200
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
39.53
Neutral
ATR (14)
2.08
Neutral
STOCH(9,6)
25.09
Neutral
STOCH RSI (14)
37.65
Neutral
ADX(9)
16.87
Bullish
UO(9)
41.07
Neutral
ROC(12)
-9.48
Bearish
WillR(14)
-74.91
Neutral
Period
Simple value
Exponential vaue
5D
16.77
16.93
10D
17.32
17.25
20D
17.87
17.97
50D
20.36
19.9
100D
22.71
21.98

About VENMAX DRUGS AND PHARMACEUTICA

VENMAX DRUGS AND PHARMACEUTICA Share Price
ISIN
INE154G01022
Sector Market Cap
₹ 19.58 Cr

Venmax Drugs and Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of pharmaceutical products, drug intermediaries and active pharmaceutical ingredients (API’s). It is developing oncology products through research and development (R&D).

VENMAX DRUGS AND PHARMACEUTICA Financial Highlights

  • Revenue: VENMAX DRUGS AND PHARMACEUTICA reported revenue of ₹8.18 crore in FY26 vs ₹1.86 crore in FY25. It showed an increase of 339.78% on a yearly basis.
  • Operating Profit: VENMAX DRUGS AND PHARMACEUTICA reported an operating profit of ₹0.28 crore in FY26 vs ₹0.01 crore in FY25. It showed an increase of 2,900.00% on a year-on-year basis.
  • Net Profit: VENMAX DRUGS AND PHARMACEUTICA reported a net profit of ₹0.25 crore in FY26 vs ₹0.01 crore in FY25. It showed an increase of 2,600.00% on a yearly basis.

VENMAX DRUGS AND PHARMACEUTICA Quarterly Result Highlights

  • VENMAX DRUGS AND PHARMACEUTICA reported revenue of ₹4.03 crore in Mar 2026, compared with ₹1.62 crore in Dec 2025, representing an increase of 148.77% on a quarter-on-quarter (QoQ) basis.
  • VENMAX DRUGS AND PHARMACEUTICA reported an operating profit of ₹0.10 crore in Mar 2026, compared with ₹0.04 crore in Dec 2025, representing an increase of 150.00% on a quarter-on-quarter (QoQ) basis.
  • VENMAX DRUGS AND PHARMACEUTICA reported a profit of ₹0.11 crore in Mar 2026, compared with ₹0.03 crore in Dec 2025, reflecting an increase of 266.67% on a QoQ basis.
  • The earnings per share (EPS) of VENMAX DRUGS AND PHARMACEUTICA stood at ₹0.02 during Mar 2026.
Know more
Promoters
10.46%
FII
0.00%
Other DII
0.00%
Retail and other
89.54%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
VENMAX DRUGS AND PHARMACEUTICA Share Price
VENMAX DRUGS AND PHARMACEUTICA
Pharmaceuticals
Add Stock
Add Another

FAQs on VENMAX DRUGS AND PHARMACEUTICA Share Price